GlassScriptPhysician profile
Abraham Fruchter
NPI 1356413074
$2,115.52
in general payments reported to CMS, 2019-2025
26 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $862 · 2020: $576 · 2021: $482 · 2022: $196.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $353.61 | 2019-2021 | |
| Glaxosmithkline, LLC. | $304.95 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $244.05 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $243.48 | 2019-2021 | |
| Amgen INC. | $148.66 | 2019-2022 | |
| Esperion Therapeutics, INC. | $118.55 | 2021-2022 | |
| Lilly USA, LLC | $108.11 | 2019-2022 | |
| Novo Nordisk INC | $101.16 | 2019-2021 | |
| Allergan, INC. | $83.18 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $61.99 | 2020-2022 | |
| Genentech USA, INC. | $42.88 | 2020 | |
| Amarin Pharma, INC. | $41.74 | 2019-2021 | |
| Pfizer INC. | $34.64 | 2019-2020 | |
| Optinose US, INC. | $33.01 | 2021-2022 | |
| Astellas Pharma US INC | $24.90 | 2019 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Indivior INC. | $22.13 | 2021 | |
| Medtronic Vascular, INC. | $18.27 | 2020 | |
| Circassia INC. | $16.95 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $16.85 | 2021 | |
| Seqirus USA INC | $15.67 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.56 | 2021 | |
| Daiichi Sankyo INC. | $14.29 | 2019 | |
| Medtronic Minimed, INC. | $13.48 | 2019 | |
| Insulet Corporation | $13.32 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.07 | 2020 | |
| Abbott Laboratories | $12.02 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abraham Fruchter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.